The Latin American dialysis equipment market size is estimated to grow USD 4.27 billion by 2027 from USD 2.93 billion in 2022, growing at a CAGR of 7.8% from 2022 to 2027.
Dialysis machines are used as a substitute for kidneys for purifying blood if kidneys couldn’t filter the blood. These machines cleanse the blood, fills it with vital substances, and remove excess liquid. These machines are permanent in case the patient is not suitable for a kidney transplant.
The prevalence of chronic kidney disease (CRF), worsened by the geriatric population and increasing life expectancy, is expected to drive demand for hemodialysis, accelerating the growth rate of the Latin American dialysis equipment market primarily. The Latin American region is characterized by a growing population and an increasing incidence of various diseases. The United Nations projects that the proportion of the Latin American population aged 65 and over will triple by the middle of the century, from 6.5% in 2005 to 21.5% in 2055. In addition, several countries in Latin America, including Brazil, Chile, and Mexico, may have populations older than the United States in the near future. Another factor influencing the growth of the market is the expansion of the patient group.
Supportive government initiatives and increased healthcare funding to increase awareness of treatment modalities are also expected to boost equipment sales during the forecast period. In addition, the introduction of technologically advanced and user-friendly dialysis equipment and the adoption of kidney dialysis instead of kidney transplantation are key trends impacting the market.
A rapidly growing number of dialysis centers and hospitals in developing countries, combined with an increasing number of patient treatments, is expected to fuel the evolution of new dialysis equipment to drive the dialysis equipment market in Latin America during the forecast period.
Restricted reimbursement is a major restraining factor for the Latin American dialysis equipment market growth. In contrast, many other factors include the lack of awareness of kidney disease, the evolution of small and medium enterprises in the highly competitive market, and the complications and risks of dialysis.
Constant innovation in the dialysis equipment market generates innovation and leads to creating complex systems to which patients and doctors alike find it hard to get used. This is the biggest challenge in the market, and it can only be tackled based on educational training and the introduction of ease of accessibility in equipment.
This research report on the Latin America Dialysis Equipment Market has been segmented and sub-segmented into the following categories:
Based on type, the dialyzers segment is expected to experience the fastest growth during the forecast period. On the other hand, the peritoneal dialysis equipment segment is expected to be another lucrative segment and forecasted to witness a CAGR of 18% by 2027.
By End User:
The demand for renal dialysis equipment in-home care facilities will increase at a higher CAGR than in-center dialysis.
Based on region, Latin America is the third attractive market after North America and Asia-Pacific owing to the growing healthcare infrastructure and growing healthcare expenditure. The Brazilian renal dialysis equipment market is expected to grow at a CAGR of 6.1% during the forecast period. As a result, Brazil accounted for the largest share of the home medical equipment market in Latin America in 2020.
In 2020, Brazil had an estimated incidence rate of 220 cases of end-stage renal disease (ESRD) treated per million population. Hence, with an increasing number of ESRD cases in Brazil, it is driving the growth of the market. Among all these hemodialysis machines, they accounted for the largest share in 2020 and are expected to grow at a high CAGR during the forecast period.
KEY MARKET PLAYERS:
Some of the noteworthy companies leading the Latin America dialysis equipment market profiled in the report are Fresenius Medical Care AG & Co., Gambro AB, Baxter International Inc., Nipro Inc., ALL-MED Medical GmbH, Asahi Kasei Corporation, and others.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org